Were any of Rodrigues’s TDOC share sales made under a Rule 10b5-1 plan?

Yes. A footnote states that one reported transaction was effected under a Rule 10b5-1 trading plan adopted by Fernando M. Rodrigues on November 3, 2025.

Teladoc exec sells 15,251 shares after RSU vesting

Q: What insider transactions did TDOC’s Fernando M. Rodrigues report on this Form 4?

He reported converting 15,251 restricted stock units into common stock on September 1, 2026, followed by sales totaling 15,251 common shares on September 2–3, 2026.

Q: At what prices did Fernando M. Rodrigues sell TDOC shares?

He sold 9,812 shares of Teladoc Health common stock at $6.51 per share on September 3, 2026, and 5,439 shares at $6.301 per share on September 2, 2026.

Q: How many TDOC restricted stock units did Rodrigues convert to common stock?

He converted a total of 15,251 restricted stock units into 15,251 shares of Teladoc Health common stock on September 1, 2026, through three RSU conversion transactions.

Q: Did Rodrigues sell TDOC shares to cover taxes on RSU vesting?

Yes. A footnote explains that 5,439 shares sold on September 2, 2026 were sold to cover the tax withholding obligation related to vesting of his restricted stock unit awards.

Q: What is the conversion ratio for Rodrigues’s TDOC restricted stock units?

A footnote states that the restricted stock units convert to shares of TDOC common stock on a one-for-one basis, so each vested unit becomes one share of common stock.

Teladoc Health’s BetterHelp president converted vested RSUs into stock and then sold 15,251 shares, including tax-withholding and Rule 10b5-1 plan sales.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) reports that Fernando M. Rodrigues, President of BetterHelp, converted a total of 15,251 restricted stock units into an equal number of common shares on September 1, 2026, then sold 15,251 common shares on September 2–3, 2026. One sale covered tax withholding on RSU vesting and another was executed under a Rule 10b5-1 trading plan adopted on November 3, 2025.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 8 txns

Insider Rodrigues Fernando M.

Role President of BetterHelp

Sold 15,251 shs ($98K)

Approx. gross sale proceeds $98K

Type	Security	Shares	Price	Value
Sale	Common Stock ^F3	9,812	$6.51	$64K
Sale	Common Stock ^F2	5,439	$6.301	$34K
Exercise	Restricted Stock Units ^{F1, F4}	5,492	$0.00	$0.00
Exercise	Restricted Stock Units ^{F1, F5}	1,042	$0.00	$0.00
Exercise	Restricted Stock Units ^{F1, F6}	8,717	$0.00	$0.00
Exercise	Common Stock ^F1	5,492	--	--
Exercise	Common Stock ^F1	1,042	--	--
Exercise	Common Stock ^F1	8,717	--	--

Holdings After Transaction: Restricted Stock Units — 59,878 contracts (Direct); Common Stock — 0 shares (Direct)

Footnotes (6)

F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.
F4. On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5. On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F6. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Shares sold September 3, 2026: 9,812 shares at $6.51 per share Shares sold September 2, 2026: 5,439 shares at $6.301 per share RSUs converted to common stock: 15,251 restricted stock units +5 more

8 metrics

Shares sold September 3, 2026 9,812 shares at $6.51 per share Open-market or private sale of Teladoc Health common stock

Shares sold September 2, 2026 5,439 shares at $6.301 per share Sale of common stock to cover tax withholding on RSU vesting

RSUs converted to common stock 15,251 restricted stock units Converted into 15,251 shares of Teladoc Health common stock on September 1, 2026

RSU grant December 1, 2023 65,894 restricted stock units Vesting one-third on first anniversary, remainder in eight quarterly installments

RSU grant March 19, 2024 12,500 restricted stock units Vesting one-third on first anniversary, remainder in eight quarterly installments from June 1, 2025

RSU grant March 1, 2025 104,602 restricted stock units Vesting one-third on March 1, 2026, remainder in eight quarterly installments

Rule 10b5-1 plan adoption date November 3, 2025 Plan under which one reported sale transaction was effected

RSU conversion ratio 1.0 Restricted stock units convert to TDOC common stock on a one-for-one basis

Key Terms

Restricted stock units, Rule 10b5-1 trading plan, tax withholding obligation, vesting

4 terms

Restricted stock units financial

"the reporting person was granted 65,894 restricted stock units, vesting one-third"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1 trading plan regulatory

"transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation in respect of vesting"

vesting financial

"vesting one-third on the first anniversary of the grant date"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did TDOC’s Fernando M. Rodrigues report on this Form 4?

He reported converting 15,251 restricted stock units into common stock on September 1, 2026, followed by sales totaling 15,251 common shares on September 2–3, 2026.

At what prices did Fernando M. Rodrigues sell TDOC shares?

He sold 9,812 shares of Teladoc Health common stock at $6.51 per share on September 3, 2026, and 5,439 shares at $6.301 per share on September 2, 2026.

How many TDOC restricted stock units did Rodrigues convert to common stock?

He converted a total of 15,251 restricted stock units into 15,251 shares of Teladoc Health common stock on September 1, 2026, through three RSU conversion transactions.

Did Rodrigues sell TDOC shares to cover taxes on RSU vesting?

Yes. A footnote explains that 5,439 shares sold on September 2, 2026 were sold to cover the tax withholding obligation related to vesting of his restricted stock unit awards.

What is the conversion ratio for Rodrigues’s TDOC restricted stock units?

A footnote states that the restricted stock units convert to shares of TDOC common stock on a one-for-one basis, so each vested unit becomes one share of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 04:08 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodrigues Fernando M.

(Last)

(First)

(Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President of BetterHelp

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/01/2026		M		5,492	A	⁽¹⁾	5,492	D
Common Stock	09/01/2026		M		1,042	A	⁽¹⁾	6,534	D
Common Stock	09/01/2026		M		8,717	A	⁽¹⁾	15,251	D
Common Stock	09/02/2026		S		5,439⁽²⁾	D	$6.301	9,812	D
Common Stock	09/03/2026		S⁽³⁾		9,812	D	$6.51	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	09/01/2026		M			5,492	⁽⁴⁾	⁽⁴⁾	Common Stock	5,492	$0	5,492	D
Restricted Stock Units	⁽¹⁾	09/01/2026		M			1,042	⁽⁵⁾	⁽⁵⁾	Common Stock	1,042	$0	2,084	D
Restricted Stock Units	⁽¹⁾	09/01/2026		M			8,717	⁽⁶⁾	⁽⁶⁾	Common Stock	8,717	$0	52,302	D

Explanation of Responses:

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

3. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.

4. On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

5. On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

6. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR